AirLogix Overview
- Founded
-
1997

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$41.2M
AirLogix General Information
Description
Provider of care-management services for respiratory disease. The company delivers patient-centric asthma and COPD programs to its members, including self-care therapies, in-home interaction and informatics, with the goals of improved clinical results, enhanced patient-provider satisfaction and cost reductions in respiratory management.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Clinics/Outpatient Services
Acquirer
Primary Office
- 5710 LBJ Freeway
- Suite 120
- Dallas, TX 75240
- United States
AirLogix Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 22-Jul-2005 | $41.2M | 000.00 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC (Series C) | 01-Mar-2002 | 00.000 | 000.00 | 000.00 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 03-Mar-2000 | $2.52M | $9.5M | 00.000 | Completed | Startup |
1. Early Stage VC (Series A) | 01-Dec-1999 | $7M | $7M | 0000 | Completed | Startup |
AirLogix Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00.00 | 00.000 | |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00.00 | 00.000 | |
Series A | 7,000,000 | $0.000100 | $0.1 | $1 | $1 | $1 | 17.48% |
AirLogix Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Cross Atlantic Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Humana Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Respironics | Corporation | Minority | 000 0000 | 000000 0 |